Proehl Gerald T - Aug 16, 2021 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role
President, CEO and Chairman, Director, 10%+ Owner
Signature
/s/ Gerald T. Proehl
Stock symbol
DRMA
Transactions as of
Aug 16, 2021
Transactions value $
$49,631
Form type
4
Date filed
8/17/2021, 12:38 PM
Previous filing
Aug 12, 2021
Next filing
Nov 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRMA Common Stock Purchase $49.6K +10K $4.96 10K Aug 16, 2021 By Proehl Family Trust F1, F8
transaction DRMA Common Stock Conversion of derivative security +17.9K 17.9K Aug 17, 2021 By Allison Taylor Proehl 2020 Irrevocable Trust F2, F8
transaction DRMA Common Stock Conversion of derivative security +8.93K 8.93K Aug 17, 2021 By Meghan Proehl Wilder 2020 Irrevocable Trust F2, F8
transaction DRMA Common Stock Conversion of derivative security +35.8K 35.8K Aug 17, 2021 By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 F2, F8
transaction DRMA Common Stock Conversion of derivative security +361K +39.37% 1.28M Aug 17, 2021 By Proehl Investment Ventures LLC F2, F8
transaction DRMA Common Stock Conversion of derivative security +112K +8.76% 1.39M Aug 17, 2021 By Proehl Investment Ventures LLC F3, F8
transaction DRMA Common Stock Conversion of derivative security +182K +13.06% 1.57M Aug 17, 2021 By Proehl Investment Ventures LLC F4, F8
transaction DRMA Common Stock Conversion of derivative security +1.25M +79.38% 2.82M Aug 17, 2021 By Proehl Investment Ventures LLC F5, F8
transaction DRMA Common Stock Conversion of derivative security +85.6K +3.04% 2.91M Aug 17, 2021 By Proehl Investment Ventures LLC F6, F8
transaction DRMA Common Stock Purchase +143K +1428.57% 153K Aug 17, 2021 By Proehl Family Trust F8, F9
holding DRMA Common Stock 39.5K Aug 16, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRMA Series 1d Preferred Stock Conversion of derivative security $0 -120K -100% $0.00* 0 Aug 17, 2021 Common Stock 17.9K By Allison Taylor Proehl 2020 Irrevocable Trust F2, F8
transaction DRMA Series 1d Preferred Stock Conversion of derivative security $0 -60.2K -100% $0.00* 0 Aug 17, 2021 Common Stock 8.93K By Meghan Proehl Wilder 2020 Irrevocable Trust F2, F8
transaction DRMA Series 1d Preferred Stock Conversion of derivative security $0 -241K -100% $0.00* 0 Aug 17, 2021 Common Stock 35.8K By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 F2, F8
transaction DRMA Series 1d Preferred Stock Conversion of derivative security $0 -2.44M -100% $0.00* 0 Aug 17, 2021 Common Stock 361K By Proehl Investment Ventures LLC F2, F8
transaction DRMA Series 1a Preferred Stock Conversion of derivative security $0 -2.3M -100% $0.00* 0 Aug 17, 2021 Common Stock 112K By Proehl Investment Ventures LLC F3, F8
transaction DRMA Series 1b Preferred Stock Conversion of derivative security $0 -3.72M -100% $0.00* 0 Aug 17, 2021 Common Stock 182K By Proehl Investment Ventures LLC F4, F8
transaction DRMA Series 1c Preferred Stock Conversion of derivative security $0 -25.6M -100% $0.00* 0 Aug 17, 2021 Common Stock 1.25M By Proehl Investment Ventures LLC F5, F8
transaction DRMA Series 1 Preferred Stock Conversion of derivative security $0 -1.76M -100% $0.00* 0 Aug 17, 2021 Common Stock 85.6K By Proehl Investment Ventures LLC F6, F8
transaction DRMA Series 1a Warrants Conversion of derivative security $0 -574K -100% $0.00* 0 Aug 17, 2021 Common Stock 28K By Proehl Investment Ventures LLC F7, F8
transaction DRMA Warrant to Purchase Common Stock Conversion of derivative security $0 +28K $0.00 28K Aug 17, 2021 Common Stock 28K $20.50 By Proehl Investment Ventures LLC F8
transaction DRMA Warrant to Purchase Common Stock Purchase +143K 143K Aug 17, 2021 Common Stock 143K $7.00 By Proehl Family Trust F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.84 to $5.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
F2 The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date.
F3 The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date.
F4 The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date.
F5 The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date.
F6 The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date.
F7 The Series 1a Preferred Warrants converted into warrants to purchase Common Stock in connection with the IPO.
F8 Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F9 Reporting Person purchased 142,857 Units in the IPO at $7.00 per Unit Each Unit consists of one share of Common Stock and one warrant to purchase one share of Common Stock.